268 related articles for article (PubMed ID: 17103289)
21. Asymptomatic gallstones and related risk factors in Iran.
Toosi FS; Ehsanbakhsh AR; Tavakoli MR
Hepatogastroenterology; 2011; 58(109):1123-6. PubMed ID: 21937362
[TBL] [Abstract][Full Text] [Related]
22. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
[TBL] [Abstract][Full Text] [Related]
23. The Prevalence and Risk Factors of Gallstone Among Adults in South-East of Iran: A Population-Based Study.
Ansari-Moghaddam A; Khorram A; Miri-Bonjar M; Mohammadi M; Ansari H
Glob J Health Sci; 2015 Jul; 8(4):60-7. PubMed ID: 26573029
[TBL] [Abstract][Full Text] [Related]
24. Cholesterol gallstones.
Kern F
Gastroenterology; 1978 Sep; 75(3):514-6. PubMed ID: 680512
[TBL] [Abstract][Full Text] [Related]
25. Determinants of transhepatic cholesterol flux and their relevance for gallstone formation.
Zanlungo S; Rigotti A
Liver Int; 2009 Mar; 29(3):323-30. PubMed ID: 19267863
[TBL] [Abstract][Full Text] [Related]
26. Triglycerides and gallstone formation.
Smelt AH
Clin Chim Acta; 2010 Nov; 411(21-22):1625-31. PubMed ID: 20699090
[TBL] [Abstract][Full Text] [Related]
27. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
van Leeuwen FE
Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
[TBL] [Abstract][Full Text] [Related]
28. Limits and perspective of oral therapy with statins and aspirin for the prevention of symptomatic cholesterol gallstone disease.
Cariati A; Piromalli E
Expert Opin Pharmacother; 2012 Jun; 13(9):1223-7. PubMed ID: 22607008
[TBL] [Abstract][Full Text] [Related]
29. Has the prevalence of cholesterol gallstones increased in Korea? A preliminary single-center experience.
Kim JW; Oh HC; Do JH; Choi YS; Lee SE
J Dig Dis; 2013 Oct; 14(10):559-63. PubMed ID: 23750885
[TBL] [Abstract][Full Text] [Related]
30. Nutritional factors (nutritional aspects) in biliary disorders: bile acid and lipid metabolism in gallstone diseases and pancreaticobiliary maljunction.
Tazuma S; Kanno K; Sugiyama A; Kishikawa N
J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():103-7. PubMed ID: 24251714
[TBL] [Abstract][Full Text] [Related]
31. Cholesterol gallstone disease.
Portincasa P; Moschetta A; Palasciano G
Lancet; 2006 Jul; 368(9531):230-9. PubMed ID: 16844493
[TBL] [Abstract][Full Text] [Related]
32. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
Khoo SK; Chick P
Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
[TBL] [Abstract][Full Text] [Related]
33. High cholesterol absorption efficiency and rapid biliary secretion of chylomicron remnant cholesterol enhance cholelithogenesis in gallstone-susceptible mice.
Wang DQ; Zhang L; Wang HH
Biochim Biophys Acta; 2005 Mar; 1733(1):90-9. PubMed ID: 15749059
[TBL] [Abstract][Full Text] [Related]
34. The role of dietary fats in the pathogenesis of gallstones.
Méndez-Sánchez N; Chavez-Tapia NC; Uribe M
Front Biosci; 2003 May; 8():e420-7. PubMed ID: 12700135
[TBL] [Abstract][Full Text] [Related]
35. [Gallbladder disease and obesity].
Méndez-Sánchez N; Chávez-Tapia NC; Uribe M
Gac Med Mex; 2004; 140 Suppl 2():S59-66. PubMed ID: 15641473
[TBL] [Abstract][Full Text] [Related]
36. Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity.
Shaffer EA; Small DM
J Clin Invest; 1977 May; 59(5):828-40. PubMed ID: 856870
[TBL] [Abstract][Full Text] [Related]
37. Physical activity, biliary lipids, and gallstones in obese subjects.
Chuang CZ; Martin LF; LeGardeur BY; Lopez A
Am J Gastroenterol; 2001 Jun; 96(6):1860-5. PubMed ID: 11419840
[TBL] [Abstract][Full Text] [Related]
38. Role of diet in cholesterol gallstone formation.
Méndez-Sánchez N; Zamora-Valdés D; Chávez-Tapia NC; Uribe M
Clin Chim Acta; 2007 Feb; 376(1-2):1-8. PubMed ID: 17055469
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis C virus infection is a risk factor for gallstone disease: a prospective hospital-based study of patients with chronic viral C hepatitis.
Acalovschi M; Buzas C; Radu C; Grigorescu M
J Viral Hepat; 2009 Dec; 16(12):860-6. PubMed ID: 19486279
[TBL] [Abstract][Full Text] [Related]
40. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
